Bayesian Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,837
| Closed | -$614K | – | 679 |
|
|
2025
Q1 | $614K | Buy |
15,837
+1,800
| +13% | +$69.7K | 0.1% | 260 |
|
|
2024
Q4 | $475K | Buy |
+14,037
| New | +$475K | 0.06% | 383 |
|
|
2023
Q3 | – | Sell |
-10,500
| Closed | -$374K | – | 816 |
|
|
2023
Q2 | $374K | Buy |
+10,500
| New | +$374K | 0.04% | 480 |
|
|
2023
Q1 | – | Sell |
-24,320
| Closed | -$855K | – | 911 |
|
|
2022
Q4 | $855K | Sell |
24,320
-27,000
| -53% | -$949K | 0.12% | 219 |
|
|
2022
Q3 | $1.51M | Buy |
+51,320
| New | +$1.51M | 0.31% | 74 |
|
|
2021
Q2 | – | Sell |
-27,860
| Closed | -$1.24M | – | 500 |
|
|
2021
Q1 | $1.24M | Buy |
+27,860
| New | +$1.24M | 0.29% | 89 |
|
|
2016
Q3 | – | Sell |
-5,584
| Closed | -$303K | – | 409 |
|
|
2016
Q2 | $303K | Buy |
5,584
+1,032
| +23% | +$56K | 0.18% | 233 |
|
|
2016
Q1 | $231K | Sell |
4,552
-1,345
| -23% | -$68.3K | 0.22% | 238 |
|
|
2015
Q4 | $297K | Buy |
+5,897
| New | +$297K | 0.43% | 101 |
|